News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Learn from the leaders at the 2025 FLASCO Early Lung Cancer Summit
FLASCO/X
Dec 30, 2024, 00:36

Learn from the leaders at the 2025 FLASCO Early Lung Cancer Summit

FLASCO shared a post on X:

“Learn from the leaders at the 2025 FLASCO early lung cancer summit.

  • January 24-25, 2025.
  • The Diplomat Beach Resort, Hollywood, Florida.

Dive into groundbreaking discussions on:

  • AIin Oncology.
  • Blood Biomarkers.

Register here.“

FLASCO

More posts featuring FLASCO.

AIin Oncology blood biomarkers cancer Cancer Summit Diplomat Beach Resort FLASCO florida hollywood leaders Lung cancer OncoDaily Oncology
Special Coverage
Blog
Dec 30, 2024, 00:36
Learn from the leaders at the 2025 FLASCO Early Lung Cancer Summit
Science
Dec 30, 2024, 00:31
3D spatial localization and volume estimation of prostate tumors
Blog
Dec 30, 2024, 00:22
Bobby Koneru: Osteoarthritis delays progression in low dose radiation therapy
Science
Dec 29, 2024, 16:39
Myeloma Paper of the Day, December 29th, suggested by Robert Orlowski
Career
Dec 29, 2024, 15:44
Colorectal Cancer Alliance is seeking a Director of Philanthropy
Blog
Dec 29, 2024, 15:40
Andreas Charalambous: Join US in Seattle in what is considered to be the best MASCC Congress ever
Insight
Dec 29, 2024, 15:34
Yüksel Ürün: Nature’s 10 honors those reshaping our world
Insight
Dec 29, 2024, 15:28
Wafaa M Rashed: Step Forward, Showcase Your Voice and Seize the Opportunity
Insight
Dec 29, 2024, 15:25
AI tool helps predicts patient responses to cancer drugs
Insight
Dec 29, 2024, 15:21
Wade Swenson: We call on Congress to enact permanent telehealth policies before March 2025
Blog
Dec 29, 2024, 15:12
Sarah Louden: Survivorship is often the loneliest chapter of the cancer journey
Science
Dec 29, 2024, 13:51
Targeting molecular pathways to control immune checkpoint inhibitor toxicities